Arcturus Therapeutics Holdings Inc. (ARCT) — QMA analysis
Sector: Healthcare · Market cap: $212M · Price: $9,84 · Data as of 2026-10-23
A composite score of 47/100 places Arcturus Therapeutics Holdings Inc. in the neutral band, higher score than 63% of 22,734 tracked stocks. The highest-scoring layer is Analysts / transcripts; the lowest is Fundamental value.
What 9 data layers say about ARCT
The composite fuses insiders, congressional trades, institutional 13F positions, fundamentals, momentum, seasonality and more into a single number.
| Layer | Score |
|---|---|
| Fundamental value (FVS) | 17/100 |
| Earnings quality (EQS) | 30/100 |
| Technical trend (TSS) | 48/100 |
| Relative strength (RS) | 55/100 |
| Momentum (USS) | 54/100 |
| Insider activity (IAS) | 21/100 |
| Off-exchange trading (FINRA) / large flows (WHS) | 45/100 |
| Analysts / transcripts (ATS) | 79/100 |
| Catalysts (XS) | 76/100 |
What does the QMA model currently show for Arcturus Therapeutics Holdings Inc.?
The composite score is a research starting point, not an instruction. What matters is layer confluence — whether the layers point in the same direction.
For ARCT the layers diverge — some score high (Analysts / transcripts), others low (Fundamental value). The divergence is itself information: the model does not give a clear-cut picture. The score is an input into your own research, not a recommendation.
ARCT insider & smart money activity
Over the recent period we record 0 reported insider purchases and 0 sales for ARCT: no reported insider trades in the period. A description of the data layer, not an instruction.
ARCT seasonality
The historically strong window for ARCT comes up November 1–28 with a hit rate of 69% and an average move of 2.7% (14 years of history).
Historical data does not guarantee future results.
ARCT dividend
Arcturus Therapeutics Holdings Inc.: 0.17%
How ARCT compares
Similar stocks from the same sector:
Frequently asked questions
What is the composite score for ARCT stock?
47/100 (C) — Data as of 2026-10-23.
Are insiders buying ARCT stock?
Over the recent period, reported: purchases 0, sales 0. Insider activity: no reported insider trades in the period — a description of reported data, not a trade instruction.
Where can I see live ARCT data?
Live ARCT data and the full screener are part of full access. Registration is free with no card — trial full access, then the free plan with a delayed data sample.
Data from SEC and public markets. QMA is an analytical tool, not a registered investment advisor. No content on this page is investment advice or an instruction to buy or sell. Past performance does not guarantee future results.
⚠️ Important Notice: QMA is an analytical and educational tool, not investment advice. Scores, detections and ratings are descriptive, not buy/sell instructions. QMA is not a registered investment advisor (SEC / FINRA / MiFID II / ČNB). Consult a licensed financial advisor before any investment. Past performance does not guarantee future results; all investments carry the risk of capital loss.
Operator: Jaroslav Vojtášek · IČO: 48783447 · Place of business: U Jízdárny 577, 747 64 Velká Polom, Czech Republic · Register: Sole trader registered in the Czech Trade Licensing Register · E-mail: [email protected]